Co-authored by Claire Watson KC and Anna Tkaczynska.
Contents
- A Introduction 5.1
- B Restraint 5.8
- Restraint permitted under the MCA 5.11
- The statutory defence 5.11
- Limits to the statutory defence 5.14
- Necessity 5.15
- Proportionality and restraint 5.16
- Restraint and Article 3 ECHR 5.18
- Covert medication and deception 5.23
- C Deprivation of liberty 5.24
- Background: ‘the Bournewood gap’ 5.24
- What is a ‘deprivation of liberty’? 5.29
- Cheshire West 5.29
- The position prior to the Supreme Court decision in Cheshire West 5.30
- The ECtHR definition 5.32
- The decision in Cheshire West 5.35
- The facts in MIG and MEG 5.35
- The facts in P v Cheshire West 5.38
- The reasoning in Cheshire West 5.40
- Identifying a deprivation of liberty: ‘a gilded cage is still a cage’ 5.45
- The acid test 5.52
- The impact of the decision in Cheshire West 5.53
- Identifying a potential deprivation of liberty in the hospital context 5.55
- Place and duration of the patient’s stay 5.59
- Deprivation of liberty for serious medical treatment: NHS Trust v FG 5.61
- Admission to an intensive care unit: R (Ferreira) v HM Senior Coroner for Inner South London 5.67
- Ferreira in the Court of Appeal 5.68
- Children and deprivation of liberty 5.70
- Children under 16 5.70
- Minors of 16–17 years 5.72
- Pointers for practitioners considering unclear cases 5.74
- Is there a deprivation of liberty? 5.74
- Contingency declarations 5.79
- D Authorising a deprivation of liberty 5.80
- Procedure 5.84
- MCA/Inherent jurisdiction? 5.85
- Review 5.86
- DOLS authorisation 5.88
- Is the patient ineligible to be detained under the MCA? 5.93
- E The Mental Capacity (Amendment) Act 2019 5.105
- Section 4B – Life-sustaining treatment or vital act 5.106
- Schedule AA1 – the LPS regime 5.107
- F Practical issues 5.115
- G Conclusion 5.120